Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Best Practice & Research. Clinical Haematology|August 18, 2021
Clonal hematopoiesis and bone marrow failure syndromesSergiu Pasca, Lukasz P GondekHematology. American Society of Hematology. Education Program|December 10, 2021
CHIP: is clonal hematopoiesis a surrogate for aging and other disease?Lukasz P GondekThe Journal of Clinical Investigation|October 15, 2019
Hitting the bullseye with a nonlethal payload: resistance in CD123-positive malignanciesLukasz P GondekNature Communications|February 18, 2026
Mitochondrial heteroplasmy is a risk factor for the development of chronic lymphocytic leukemiaSergiu Pasca, Yun Soo Hong, Wen Shi, et al.Blood Advances|February 26, 2020
Stem cell donors should be screened for CHIPAmy E DeZern, Lukasz P GondekCurrent Hematologic Malignancy Reports|August 1, 2014
I walk the line: how to tell MDS from other bone marrow failure conditionsLukasz P Gondek, Amy E DeZernThe Lancet. Haematology|December 8, 2019
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor statesLukasz P Gondek, Amy E DeZernBlood Advances|April 19, 2024
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignanciesPhilip H Imus, Sergiu Pasca, Hua-Ling Tsai, et al.Leukemia Research|June 24, 2023
Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophiliaTania Jain, Alisha D Ware, William Brian Dalton, et al.The Prostate|April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancerCatherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.Pageof 13